--- title: Case report Humanization --- [![logo_blanc-300](https://go.proteogenix.science/hs-fs/hubfs/logo_blanc-300.png?width=235&height=140&name=logo_blanc-300.png)](https://www.proteogenix.science) # Successful antibody humanization for cervical cancer therapy with improved binding ## **Turning a lead antibody into a safer candidate powered by AI** Discover how our AI-driven antibody humanization expertise helped a small French biotech reach **80% human sequence homology**—making the antibody **safer and more market-ready** for cervical cancer therapy. ![humanization](https://go.proteogenix.science/hs-fs/hubfs/humanization.png?width=999&height=666&name=humanization.png) ### Complete the form and receive free case report! # This Case Report includes: - - A step-by-step humanization workflow combining AI to reduce immunogenicity risk  - - Detailed results and variant comparisons, including how lead candidates were selected - - 3D structural exploration - - Deliverables that accelerate decisions: full report, complete sequence set, and 3 lead candidate samples for next-stage of the project --- --- --- --- [![ft_logo](https://go.proteogenix.science/hubfs/ft_logo.svg)](https://www.proteogenix.science/) © 2026 ProteoGenix | All rights reserved | [Legal notices](https://www.proteogenix.science/legal-notices/)